Press releases

Scientists from The Pirbright Institute’s Vaccine Differentiation group have recently returned from Chennai in India, where they conducted a mass peste des petits ruminants (PPR) vaccination campaign and awareness programme. The trip marked the end of a four year collaborative project that has successfully uncovered important details about the PPR virus and generated tools to help eradicate the disease.

Researchers in the UK, led by The Pirbright Institute are to receive £3.1 million of investment to produce a more affordable and effective vaccine to protect animals against foot-and-mouth disease (FMD).

Foot-and-mouth disease is endemic in large parts of Africa, South America, the Middle East and Asia and, globally, is the most economically important infectious disease of livestock, affecting cattle, pigs, sheep and goats and other cloven-footed animals.

Researchers at The Pirbright Institute in collaboration with partners at the USDA Animal and Plant Health Inspection Service (APHIS) Foreign Animal Disease Diagnostic Laboratory on Plum Island USA, have shown that foot-and-mouth disease virus (FMDV) can be detected in milk samples using a method that is potentially sensitive enough to identify the virus in pooled milk stored in bulk tanks or milk tankers. These encouraging results indicate that testing of milk samples could contribute to disease surveillance both during and after outbreaks.

Scientists from The Pirbright Institute are spearheading a 31 member consortium named ‘DEFEND’ which has been awarded €5.6 million by the European Union Horizon 2020 programme to study two viral diseases that are emerging into Europe; African swine fever (ASF) and lumpy skin disease (LSD).